Jack Nathan Health Announces Its Q4 and Year End Fiscal 2025 Financial Results
Disclosure Regarding Filing Timing
As previously disclosed in a press release issued on June 9, 2025, the Company was unable to file its annual financial statements, MD&A, and related CEO and CFO certifications for the fiscal year ended January 31, 2025, by the prescribed filing deadline of May 31, 2025. The delay was due to operational restructuring, resource realignment, and transition impacts following the divestiture of its Canadian primary care operations and the winding down of Mexico operations. The Company is pleased to confirm that it has now completed the filings within the 90-day permitted period, and all required documents are available on SEDAR+.
Management Commentary
Mike Marchelletta, Chief Executive Officer, commented:
'Fiscal 2025 was a pivotal year of transition for Jack Nathan Health. We successfully completed the divestiture of our Canadian primary care and licensee business, which significantly improved our balance sheet and eliminated legacy obligations. Following year-end, we also ceased all clinic operations in Mexico after the termination of our agreement with Walmart Mexico. With both legacy business segments now exited, our current focus is on internal restructuring, stabilizing our operations, and preserving cash while evaluating future strategic opportunities. We believe these actions have positioned the Company for a more focused path forward.'
Financial Highlights for the fiscal year ended January 31, 2025
Operating Results
2025
2024
2023
$ $
Revenues (Continuing + Discontinued)
19,146,626
19,144,923
15,487,698
Net loss from continuing operations
(2,530,374)
(1,333,217)
(6,902,759)
Net Income/(loss) from discontinued operations
9,995,129
(5,302,750)
-
Total comprehensive income/ (loss)
7,678,435
(6,737,300)
(7,077,020)
For the fiscal year ended January 31, 2025, total consolidated revenues were $19.1 million, consistent with the prior year. Revenues from continuing operations increased 26% to $8.7 million driven by the full-year contribution from MedSpa operations and the continued activity of the Mexico division through fiscal year-end. MedSpa revenues were $1.03 million, up 90% year-over-year. Discontinued operations contributed $10.4 million in revenue prior to the sale of the Canadian medical clinic and licensee business on December 1, 2024.
Note on Mexico Operations:
The 2025 financial statements reflect the Mexico clinic operations as part of continuing operations, as these locations were active through January 31, 2025. However, subsequent to year-end, all operations in Mexico were fully ceased as of June 30, 2025 following the formal termination of the Company's agreement with Walmart Mexico. As such, the Mexico division is no longer part of Jack Nathan Health's active business going forward.
The Company reported a loss from continuing operations of $2.5 million, compared to $1.3 million in the prior year. However, discontinued operations yielded a net gain of $9.99 million, largely driven by a $16.4 million gain on the sale of the Canadian operations.
Balance Sheet as of January 31, 2025
Cash of $2.2 million (January 31, 2024 - $3.06 million)
Total assets of $3.54 million (January 31, 2024 - $11.19 million)
Total liabilities of $2.22 million (January 31, 2024 - $17.13 million)
Working capital improved to $1.4 million, compared to a working capital deficit of $0.5 million the year prior.
Shares Outstanding
As of January 31, 2025, the Company had 87,099,159 common shares outstanding, 1,650,000 stock options outstanding and 335,004 DSUs outstanding.
For further information regarding the Company's financial results for fiscal year ended January 31, 2025, please refer to the audited annual consolidated financial statements of the Company as at and for the 12 months ended January 31, 2025 together with the corresponding MD&A, available at www.sedarplus.ca and the JNH website https//investor.jnhmexico.com
About Jack Nathan Medical Corp.
Jack Nathan Health® is a provider of MedSpa services in Canada and a former operator of one of the largest retail medical clinic networks in North America. Established in 2006 the Company expanded its international footprint, delivering exceptional, state-of-the-art, turn-key medical centers in 253 locations globally, with 193 corporately owned and operated. In Canada, the Company grew to 82 locations, including 80 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec and 2 independent locations, with 22 corporate owned and operated clinics of which 3 included Rehab services and 6 included MedSpa services. In Mexico, the Company grew to 171 corporate owned clinics across Mexico within 3 divisions, including 165 retail clinics, 5 clinics inside Walmart Distribution Centers servicing Walmart Associates, and 1 multidisciplinary clinic. In December 2024, Jack Nathan Health restructured its Canadian medical operations through an asset sale to Well Health Technologies Corp. Following the exit from its Walmart Mexico operations in May 2025, the Company continues to operate its Canadian MedSpa clinics and is actively evaluating strategic opportunities for its future business in Canada, Mexico & USA.
For more information, visit https//investor.jnhmexico.com or www.sedarplus.ca.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Appendix:
Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to Jack Nathan are intended to identify forward- looking information. All statements other than statements of historical fact may be forward- looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to them, and are subject to certain risks, uncertainties, and assumptions Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Such factors include but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative and other judicial, regulatory, political, and competitive developments; and operational difficulties. This list is not exhaustive of the factors that may affect forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward- looking information. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward- looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward- looking information, other than as required by applicable law.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
an hour ago
- Winnipeg Free Press
Another day, another Trump tariff threat
Opinion We apologize. We apologize deeply for going back to the same ground we worked in our July 11 editorial, when we said, about U.S. President Donald Trump's 50 per cent tariff levy on Brazil, 'It was Canada a couple of weeks ago, when Trump was railing about the unfairness of a Canadian dairy tariff that he actually agreed to in the last Canada-U.S.-Mexico trade pact and that hasn't been levied, and it's Brazil's turn now. And it will be Canada again.' Because it is Canada. Again. Demetrius Freeman/The Washington Post U.S. President Donald Trump Thursday night, on his own social media outlet, Trump posted a letter that he was sending to Prime Minister Mark Carney, decrying drugs 'pouring into our Country' from Canada, and complaining about the aforementioned tariff on dairy products. (Which American dairy exporters would face if they reached certain export levels — which they never have reached, and hence, are tariffs they never have paid. But why bother to worry about facts?) The letter starts out 'It is a great honour for me to send you this letter in that it demonstrates the strength and commitment of our trading relationship, and the fact that the United States has agreed to continue working with Canada, despite Canada having financially retaliated against the United States…' Trump then goes on to say that he is ordering a 35 per cent tariff on Canadian products to come into effect on Aug. 1, over and above tariffs already announced on steel, aluminum and auto parts, and threatens to increase that rate if Canada retaliates with tariffs of its own. It doesn't explain whether, like his last threat of 10 per cent or 20 per cent, the tariff only applies to products outside the CUSMA trade agreement. 'If Canada works with me to stop the flow of fentanyl, we will, perhaps, consider an adjustment to this letter. These tariffs may be modified upwards or downwards, depending on our relationship with your country. You will never be disappointed with the United States of America. Thank you for your attention to this matter.' Far from never being disappointed, we are, in fact, deeply disappointed with the United States of America. Or, at least, with its threatener-in-chief. He does not negotiate in good faith, he changes his demands and the reasons for them at the drop of a hat, and seems to think that disrupting global trade, roiling global financial markets and upending relationships with long-standing friendly nations is somehow 'doing business.' It's not. At this point, we should be looking at cutting our losses in the best way we can. It's time to leave Trump behind: we can make nice in trade talks, do our best to mollify a president who can't even be bothered to use facts to bolster his 'national security' tariffs, but in every possible way, we should be moving to separate ourselves from trade with the United States under Trump. Wednesdays A weekly dispatch from the head of the Free Press newsroom. We should avoid American products, decline to vacation or travel in the United States, and refuse to absorb American tariffs into the prices Canadian sellers charge American customers. Americans should feel the full cost of their president's unilateral 'negotiations.' As well, we should look to enter trade agreements with nations that negotiate honestly and fairly, and that then live up to the terms and spirit of those negotiations. And move every bit of trade we can to those countries. It took just seven hours from when our earlier editorial was written until Trump proved the editorial's central thesis to be correct: 'There is a simple truth President Trump is making more and more clear with each passing day and each passing edict. If you give in to blackmail, the blackmailer will just come back later for more.' He'll be back, demanding even more. Depend on it.
Globe and Mail
2 hours ago
- Globe and Mail
3 High-Yielding Dividend Stocks You Can Buy for Less Than $100
Key Points These stocks all yield more than three times the S&P 500 average. Together, they can help diversify your portfolio while adding plenty of income and stability over the long haul. 10 stocks we like better than Realty Income › Want some modestly priced stocks that also pay high dividends? It can be challenging finding a quality stock that fits that criteria, but there are three that can be excellent options worth considering today: Realty Income (NYSE: O), AT&T (NYSE: T), and Toronto-Dominion Bank (NYSE: TD). These stocks are all trading at less than $100 per share, offer high yields that are more than three times the S&P 500 (SNPINDEX: ^GSPC) average of 1.2%, and can be relatively safe investments to simply buy and hold for the long haul. Here's a look at how much these stocks pay, and why they are good investments to put into your portfolio right now. 1. Realty Income On Monday, real estate investment trust (REIT) Realty Income closed at a price of $57.53. This year, the stock has risen by nearly 8%, giving investors some decent gains to go along with a fairly high yield of 5.6%. Not only is Realty Income's high dividend appealing, but the REIT makes payments on a monthly basis. Unlike most other dividend stocks, you can collect a much more frequent payout with this investment. The REIT also prides itself on stability and consistency; it has declared a dividend for 660 straight months. In June, it also announced that it would be increasing the rate of its monthly dividend for the 131st time in its history. This year looks to be another solid year for the business, as Realty Income expects occupancy levels of more than 98% and same-store rent growth of around 1%. Its funds from operations for the first three months of the year came in at $1.05, up from $0.94 in the same period last year. The company is diversified across 91 industries and is in multiple markets, making it a fairly safe investment to put in your portfolio. For buy-and-hold investors, this can be a no-brainer income stock to hang on to. 2. AT&T Telecom giant AT&T trades at around $30 per share and is a modestly priced stock you can pick up right now. Despite soaring more than 50% over the past 12 months, the dividend stock only trades at 17 times its trailing earnings, which is modest in comparison to the average stock on the S&P 500, which trades at a multiple of 24. AT&T's dividend yields 3.8%, and while the company hasn't raised its payout for multiple years, it may only be a matter of time before that happens. Its financials have been looking good, with the company expecting free cash flow of at least $16 billion this year -- far more than the $8.3 billion it pays out in dividends on an annual basis. AT&T also makes for an underrated growth stock, as the company is in the process of acquiring Lumen 's Mass Markets fiber business, which will nearly double the amount of fiber locations it is in by the end of 2030, to around 60 million. If you want a combination of a high yield and some good growth potential, AT&T is a stock worth considering today. 3. Toronto-Dominion Bank Toronto-Dominion Bank is a top Canadian-based bank that can make for a reliable long-term investment. It yields 4.1%, which is a fairly strong payout for a top bank stock. Over a period of five years, TD has increased its quarterly dividend by 42%, for an average compounded annual growth rate of 7.2%. The bank has operations in the U.S., but due to lax anti-money laundering procedures, it was hit with a $3 billion fine last year and has an asset cap in place in the U.S. as a result of its settlement with regulators. But as a long-term play, this can still make for an excellent investment. TD is among the largest banks in North America, and over the trailing 12 months, it has posted a profit of 16.8 billion Canadian dollars on revenue totaling CA$58.8 billion, for a terrific profit margin of around 29%. Trading at around $74 and just 1.5 times its book value, TD can be a good value pickup for income investors today. Should you invest $1,000 in Realty Income right now? Before you buy stock in Realty Income, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Realty Income wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,764!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $980,723!* Now, it's worth noting Stock Advisor 's total average return is1,048% — a market-crushing outperformance compared to179%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 7, 2025
CTV News
3 hours ago
- CTV News
CTV National News: New report shows how Alberta is lagging behind in health care
Watch A new report finds Alberta's health care system is falling short in significant sectors compared to the rest of Canada. Kathy Le breaks it down.
